# Meditrina Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meditrina-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Ann Arbor, US
- Website: www.meditrina.com
- Total disclosed funding: $4.4M
- Latest round: Series A (Apr 4, 2007)
- Investors on record: 1

## About

Meditrina Pharmaceuticals Inc. specializes in the provision of domain registration and acquisition services, primarily facilitating the buying and selling of premium domain names for businesses and individuals seeking to enhance their online presence.Founded in 2006, Meditrina Pharmaceuticals Inc. is headquartered in Ann Arbor, US. The company focuses on domain registration and acquisition services. It has engaged in four investment deals, with the most recent being a Venture Debt round on December 28, 2010, where it raised USD 0.050 mn, contributing to a total of USD 4.400 mn raised to date.Meditrina.com, operated by Synergy Technologies, LLC, specializes in domain registration and acquisition services. The company provides domain name appraisal, brokerage services, and transfer assistance, primarily targeting startups and established businesses seeking impactful digital branding opportunities, particularly in North America and Europe.Synergy Technologies, LLC generates revenue through domain transactions, including brokerage fees and commissions from domain sales. Revenue is obtained via direct consultations with clients, and the company also engages in service contracts for premium services like domain appraisal and ongoing management of digital assets.Following its recent funding round in December 2010, where Meditrina Pharmaceuticals Inc. raised USD 0.050 mn, the company plans to enhance its product offerings related to domain services. It aims to expand into new geographic markets, focusing on emerging regions in Europe and Asia by 2025, leveraging the funds to support these growth initiatives.

## Funding rounds

- Series A, Apr 4, 2007, $4.4M — 21st Century Group

## Investors

- 21st Century Group (https://capitalatlas.ai/funds/21st-century-group) — Series A